Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Fang, Fang ^a   Chen, Honglei ^b   Wirdefeldt, Karin ^a   Ronnevi, Lars Olof ^a   Al Chalabi, Ammar ^c   Peters, Tracy L ^a   Kamel, Freya ^b   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEPSIS; SWEDEN; CASE CONTROL STUDY;

AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM INFECTIONS; HUMANS; SEPSIS; SWEDEN;

EID: 84455173056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029749     Document Type: Article

References (29)

1. Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, et al. (2010) An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81: 1324-1326.
2. Andersen PM, Al-Chalabi A, (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol.
3. Al-Chalabi A, Lewis CM, (2011) Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum Hered 71: 281-288.
4. Troost D, Van den Oord JJ, Vianney de Jong JM, (1990) Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 16: 401-410.
5. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
6. Philips T, Robberecht W, (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10: 253-263.
7. Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, et al. (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58: 231-243.
8. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH, (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25: 9275-9284.
9. Salazar-Grueso EF, Roos RP, (1995) Amyotrophic lateral sclerosis and viruses. Clin Neurosci 3: 360-367.
10. Jubelt B, (1992) Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas. Curr Opin Neurol Neurosurg 5: 655-658.
11. Berger MM, Kopp N, Vital C, Redl B, Aymard M, et al. (2000) Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 54: 20-25.
12. Giraud P, Beaulieux F, Ono S, Shimizu N, Chazot G, et al. (2001) Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology 56: 1777-1778.
13. Jokelainen M, (1976) The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. J Neurol Sci 29: 55-63.
14. Leone M, Chandra V, Schoenberg BS, (1987) Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology 37: 1339-1343.
15. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB, (2005) Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 25: 144-152.
16. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, et al. (2008) Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler 9: 59-62.
17. Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, et al. (2008) Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 15: 1245-1251.
18. Kurian KM, Forbes RB, Colville S, Swingler RJ, (2009) Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry 80: 84-87.
19. Gedeborg R, Furebring M, Michaelsson K, (2007) Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol 60: 155-162.
20. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, et al. (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11: 450.
21. Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, et al. (2009) Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol 66: 515-519.
22. Hanisch UK, Kettenmann H, (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
23. Wyss-Coray T, Mucke L, (2002) Inflammation in neurodegenerative disease--a double-edged sword. Neuron 35: 419-432.
24. Andersson PB, Perry VH, Gordon S, (1992) The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48: 169-186.
25. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
26. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, et al. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11: 251-253.
27. Dunn N, Mullee M, Perry VH, Holmes C, (2005) Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 19: 91-94.
28. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, et al. (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74: 788-789.
29. Ebert S, Goos M, Rollwagen L, Baake D, Zech WD, et al. (2010) Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases. J Neurosci Res 88: 1124-1136.